Patent Number: 7,713,974

Title: Non-nucleoside reverse transcriptase inhibitors

Abstract: The present invention provides for compounds useful for treating an HIV infection, or preventing an HIV infection, or treating AIDS or ARC. The compounds of the invention are of formula I wherein A is A1, A2, A3 or A4 and R.sup.1, R.sup.2, R.sup.3, R.sup.4a, R.sup.4b, R.sup.5, R.sup.6, Ar, X.sup.1, X.sup.2, X.sup.4, X.sup.4 and X.sup.5 are as herein defined. Also disclosed in the present invention are methods of treating an HIV infection with compounds defined herein and pharmaceutical compositions containing said compounds. ##STR00001##

Inventors: Kennedy-Smith; Joshua (San Francisco, CA), Palmer; Wylie Solang (Mountain View, CA), Sweeney; Zachary Kevin (Redwood City, CA)

Assignee: Roche Palo Alto LLC

International Classification: C07D 487/04 (20060101); A61K 31/4985 (20060101); A61P 31/18 (20060101); A61K 31/407 (20060101); A61K 31/415 (20060101); C07D 471/04 (20060101); C07D 231/56 (20060101); C07D 231/20 (20060101); C07D 231/12 (20060101); A61K 31/519 (20060101)

Expiration Date: 5/11/12018